Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Clinical trial NCT04282187 · RECRUITING

Trial details

NCT number: NCT04282187
Sponsor: University of Washington
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Essential Thrombocythemia Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasm Myeloproliferative Neoplasm Myeloproliferative Neoplasm, Not Otherwise Specified Polycythemia Vera Primary Myelofibrosis Secondary Myelofibrosis

Start date: 2020-03-24
Primary completion: 2026-11-11
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.